Literature DB >> 6086501

A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques.

M H Jeggo, R C Wardley, J Brownlie.   

Abstract

The transfer of thoracic duct lymphocytes from sheep inoculated 14 days, but not 7 days previously with bluetongue virus into their monozygotic twin resulted in some protection from challenge with bluetongue virus. T cell enrichment of the 14 day thoracic duct lymphocyte population resulted in a similar effect, indicating the T cell basis of the observed protection. Animals recovered from infection with bluetongue virus type 3 and which received thoracic duct lymphocytes from an identical twin recently infected with the same bluetongue virus type were protected from challenge with bluetongue type 4. These observations suggest that T lymphocytes play an important role in protection against bluetongue virus.

Entities:  

Mesh：

Year:  1984        PMID： 6086501      PMCID： PMC1454488     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  7 in total

1.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

2.  Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia.

Authors:  M A Wells; F A Ennis; P Albrecht
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

3.  Peanut agglutinin (PNA)-binding properties of murine thymocyte subpopulation.

Authors:  F Dumont; J Nardelli
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

4.  Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.

Authors:  K K Sethi; Y Omata; K E Schneweis
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

5.  Cross-reactivity for different type A influenza viruses of a cloned T-killer cell line.

Authors:  L Y Lu; B A Askonas
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

6.  Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types.

Authors:  M H Jeggo; R C Wardley
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Clinical and serological response of sheep to serial challenge with different bluetongue virus types.

Authors:  M H Jeggo; I D Gumm; W P Taylor
Journal:  Res Vet Sci       Date:  1983-03       Impact factor: 2.534
  7 in total
  18 in total

1.  Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep.

Authors:  M A Ramakrishnan; A B Pandey; K P Singh; R Singh; S Nandi; M L Mehrotra
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

Review 2.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

3.  Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses.

Authors:  H Takamatsu; M H Jeggo
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR.

Authors:  S J Brodie; W C Wilson; P M O'Hearn; D Muthui; K Diem; L D Pearson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

6.  Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock.

Authors:  David J Paton; Geraldine Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

7.  Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.

Authors:  Eva Calvo-Pinilla; Nicolás Navasa; Juan Anguita; Javier Ortego
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Authors:  Ana Cristina Pérez de Diego; Pedro José Sánchez-Cordón; Ana Isabel de las Heras; José Manuel Sánchez-Vizcaíno
Journal:  ScientificWorldJournal       Date:  2012-04-24

9.  Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.

Authors:  Verónica Martín; Elena Pascual; Miguel Avia; Lourdes Peña; Félix Valcárcel; Noemí Sevilla
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.

Authors:  José M Rojas; Lourdes Peña; Verónica Martín; Noemí Sevilla
Journal:  Vet Res       Date:  2014-03-12       Impact factor: 3.683
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.